Sort
35,931 grants matching “parkinsons”
WINCS and DBS
$329,577Kendall H. Lee · Mayo Clinic Rochester · R01 · FY2013 · NS
Development of Dopaminergic Neurons in Zebrafish
$329,570Su Guo · University Of California, San Francisco · R01 · FY2007 · NS
Modulating Inhibitory Action Control Systems With Subthalamic Nucleus Stimulation
$329,567Nelleke C. Van Wouwe · University Of Louisville · R01 · FY2021 · NS
Rare-event simulation and analysis for elucidating mechanisms of development and disease
$329,565Aaron Dinner · University Of Chicago · R35 · FY2022 · GM
Rare-event simulation and analysis for elucidating mechanisms of development and disease
$329,565Aaron Dinner · University Of Chicago · R35 · FY2024 · GM
Rare-event simulation and analysis for elucidating mechanisms of development and disease
$329,565Aaron Dinner · University Of Chicago · R35 · FY2023 · GM
Rare-event simulation and analysis for elucidating mechanisms of development and disease
$329,565Aaron Dinner · University Of Chicago · R35 · FY2021 · GM
Somatic Cell Gene Transfer/Neurological & Clinical Applications
$329,559Matthew J During · Ohio State University · R01 · FY2008 · NS
Mechanisms of Shear Induction of Blood-Brain Barrier Phenotypes in Human iPSC-derived Brain Endothelial Progenitors
$329,554Sean P Palecek · University Of Wisconsin-Madison · R01 · FY2019 · NS
Pore opening: A target for mitochondrial DNA mutations
$329,544Saint Louis University · R01 · FY2001 · NS
Pharmacology and Regulation of Nicotinic Receptor Subtypes
$329,523Kenneth J Kellar · Georgetown University · R01 · FY2008 · DA
Choroid Plexus as a Target in Metal-Induced Neurotoxicity
$329,500Wei Zheng · Purdue University · R01 · FY2006 · ES
ATP13A2 and Susceptibility to Neurodegeneration
$329,485Sheila Fleming · Northeast Ohio Medical University · R01 · FY2023 · ES
ATP13A2 and Susceptibility to Neurodegeneration
$329,485Sheila Fleming · Northeast Ohio Medical University · R01 · FY2024 · ES
Gene Regulation and DNA Damage in the Aging Brain
$329,469Bruce A Yankner · Harvard Medical School · R01 · FY2007 · AG
A Drosophila model for studying mechanisms of Gaucher's disease and synucleinopathies
$329,468Leo J Pallanck · University Of Washington · R01 · FY2015 · NS
Dopaminergic modulation of spinal locomotor circuits
$329,459Mark A Masino · University Of Minnesota · R01 · FY2019 · NS
Dopaminergic modulation of spinal locomotor circuits
$329,459Mark A Masino · University Of Minnesota · R01 · FY2020 · NS
Dopaminergic modulation of spinal locomotor circuits
$329,459Mark A Masino · University Of Minnesota · R01 · FY2018 · NS
Clearance and In Vivo Detection of Tau Pathology
$329,444Einar M Sigurdsson · New York University School Of Medicine · R01 · FY2012 · AG
Clearance and In Vivo Detection of Tau Pathology
$329,444Einar M Sigurdsson · New York University School Of Medicine · R01 · FY2011 · AG
Clearance and In Vivo Detection of Tau Pathology
$329,443Einar M Sigurdsson · New York University School Of Medicine · R01 · FY2013 · AG
Long-term consequences of methamphetamine toxicity
$329,443Kristen A Keefe · University Of Utah · R01 · FY2010 · DA
Altered lysosomal degradation in PD
$329,429Columbia University Health Sciences · P50 · FY2004 · NS
Mechanisms of Manganese Neurotoxicity
$329,420Michael Aschner · Vanderbilt University · R01 · FY2011 · ES